Literature DB >> 30571536

Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes.

S Jeson Sangaralingham1, John C Burnett1.   

Abstract

Entities:  

Keywords:  Editorials; hypertension; natriuretic peptide, C-type; pericytes; relaxation

Mesh：

Substances：

Year:  2018        PMID： 30571536      PMCID： PMC6309907          DOI： 10.1161/CIRCULATIONAHA.118.035132

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity.

Authors:  Kazuhiro Nakao; Koichiro Kuwahara; Toshio Nishikimi; Yasuaki Nakagawa; Hideyuki Kinoshita; Takeya Minami; Yoshihiro Kuwabara; Chinatsu Yamada; Yuko Yamada; Takeshi Tokudome; Chiaki Nagai-Okatani; Naoto Minamino; Yoko M Nakao; Shinji Yasuno; Kenji Ueshima; Masakatsu Sone; Takeshi Kimura; Kenji Kangawa; Kazuwa Nakao
Journal:  Hypertension       Date:  2017-01-03       Impact factor: 10.190

2.  B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.

Authors:  Sara J Holditch; Claire A Schreiber; Ryan Nini; Jason M Tonne; Kah-Whye Peng; Aron Geurts; Howard J Jacob; John C Burnett; Alessandro Cataliotti; Yasuhiro Ikeda
Journal:  Hypertension       Date:  2015-05-11       Impact factor: 10.190

3.  Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population.

Authors:  S Jeson Sangaralingham; Paul M McKie; Tomoko Ichiki; Christopher G Scott; Denise M Heublein; Horng H Chen; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

4.  Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging.

Authors:  S Jeson Sangaralingham; Denise M Heublein; Joseph P Grande; Alessandro Cataliotti; Andrew D Rule; Paul M McKie; Fernando L Martin; John C Burnett
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-24

5.  A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.

Authors:  Valentina Cannone; Guido Boerrigter; Alessandro Cataliotti; Lisa C Costello-Boerrigter; Timothy M Olson; Paul M McKie; Denise M Heublein; Brian D Lahr; Kent R Bailey; Maurizio Averna; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

6.  Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

Authors:  P M Oliver; J E Fox; R Kim; H A Rockman; H S Kim; R L Reddick; K N Pandey; S L Milgram; O Smithies; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.

Authors:  S W John; J H Krege; P M Oliver; J R Hagaman; J B Hodgin; S C Pang; T G Flynn; O Smithies
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

Review 8.  Molecular Physiology of Membrane Guanylyl Cyclase Receptors.

Authors:  Michaela Kuhn
Journal:  Physiol Rev       Date:  2016-04       Impact factor: 37.312

9.  Cardiovascular and renal actions of C-type natriuretic peptide.

Authors:  A J Stingo; A L Clavell; L L Aarhus; J C Burnett
Journal:  Am J Physiol       Date:  1992-01

10.  Endothelial C-type natriuretic peptide maintains vascular homeostasis.

Authors:  Amie J Moyes; Rayomand S Khambata; Inmaculada Villar; Kristen J Bubb; Reshma S Baliga; Natalie G Lumsden; Fang Xiao; Paul J Gane; Anne-Sophie Rebstock; Roberta J Worthington; Michela I Simone; Filipa Mota; Fernando Rivilla; Susana Vallejo; Concepción Peiró; Carlos F Sánchez Ferrer; Snezana Djordjevic; Mark J Caulfield; Raymond J MacAllister; David L Selwood; Amrita Ahluwalia; Adrian J Hobbs
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808
View more
  4 in total

1.  C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.

Authors:  Yang Chen; Ye Zheng; Seethalakshmi R Iyer; Gerald E Harders; Shuchong Pan; Horng H Chen; Tomoko Ichiki; John C Burnett; S Jeson Sangaralingham
Journal:  J Mol Cell Cardiol       Date:  2019-04-04       Impact factor: 5.000

2.  C-Type Natriuretic Peptide Ameliorates Vascular Injury and Improves Neurological Outcomes in Neonatal Hypoxic-Ischemic Brain Injury in Mice.

Authors:  Guofang Shen; Shirley Hu; Zhen Zhao; Lubo Zhang; Qingyi Ma
Journal:  Int J Mol Sci       Date:  2021-08-20       Impact factor: 6.208

3.  C-Type Natriuretic Peptide Plays an Anti-Inflammatory Role in Rat Epididymitis Induced by UPEC.

Authors:  Chunlei Mei; Yafei Kang; Chenlu Zhang; Chunyu He; Aihua Liao; Donghui Huang
Journal:  Front Cell Infect Microbiol       Date:  2021-08-12       Impact factor: 5.293

Review 4.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.